MedPath

华兰基因工程有限公司

Ownership
-
Established
2013-06-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Bevacizumab Injection

Product Name
安贝优
Approval Number
国药准字S20240051
Approval Date
Nov 15, 2024
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath